J&J Eyes Big Sale of Its Orthopedics Business DePuy Synthes

Johnson & Johnson is exploring a potential $20B+ sale of its orthopedics unit DePuy Synthes instead of spinning it off, drawing interest from private equity firms in a major healthcare deal.